202 related articles for article (PubMed ID: 23656203)
1. Efficacy and safety of oral tranexamic acid in women with heavy menstrual bleeding and fibroids.
Eder S; Baker J; Gersten J; Mabey RG; Adomako TL
Womens Health (Lond); 2013 Jul; 9(4):397-403. PubMed ID: 23656203
[TBL] [Abstract][Full Text] [Related]
2. Uterine artery blood flow parameters in women with dysfunctional uterine bleeding and uterine fibroids: the effects of tranexamic acid.
Lakhani KP; Marsh MS; Purcell W; Hardiman P
Ultrasound Obstet Gynecol; 1998 Apr; 11(4):283-5. PubMed ID: 9618854
[TBL] [Abstract][Full Text] [Related]
3. A dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleeding.
Freeman EW; Lukes A; VanDrie D; Mabey RG; Gersten J; Adomako TL
Am J Obstet Gynecol; 2011 Oct; 205(4):319.e1-7. PubMed ID: 21777897
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
5. Oral modified-release tranexamic acid for heavy menstrual bleeding.
Hrometz SL
Ann Pharmacother; 2012; 46(7-8):1047-53. PubMed ID: 22811348
[TBL] [Abstract][Full Text] [Related]
6. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial.
Lukes AS; Moore KA; Muse KN; Gersten JK; Hecht BR; Edlund M; Richter HE; Eder SE; Attia GR; Patrick DL; Rubin A; Shangold GA
Obstet Gynecol; 2010 Oct; 116(4):865-875. PubMed ID: 20859150
[TBL] [Abstract][Full Text] [Related]
7. Oral micronised flavonoids versus tranexamic acid for treatment of heavy menstrual bleeding secondary to copper IUD use: a randomised double-blind clinical trial.
Alanwar A; Abbas AM; Hussain SH; Elhawwary G; Mansour DY; Faisal MM; Elshabrawy A; Eltaieb E
Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):365-370. PubMed ID: 30247074
[TBL] [Abstract][Full Text] [Related]
8. Daily menstrual blood loss and quality of life in women with heavy menstrual bleeding.
Lukes AS; Baker J; Eder S; Adomako TL
Womens Health (Lond); 2012 Sep; 8(5):503-11. PubMed ID: 22934724
[TBL] [Abstract][Full Text] [Related]
9. Antifibrinolytics for heavy menstrual bleeding.
Lethaby A; Farquhar C; Cooke I
Cochrane Database Syst Rev; 2000; (4):CD000249. PubMed ID: 11034679
[TBL] [Abstract][Full Text] [Related]
10. The medical management of abnormal uterine bleeding in reproductive-aged women.
Bradley LD; Gueye NA
Am J Obstet Gynecol; 2016 Jan; 214(1):31-44. PubMed ID: 26254516
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic studies in women of 2 novel oral formulations of tranexamic acid therapy for heavy menstrual bleeding.
Moore KA; Morin I; Marenco T; Lavigne JR; Morelli G
Am J Ther; 2012 May; 19(3):190-8. PubMed ID: 21248612
[TBL] [Abstract][Full Text] [Related]
12. An Open-Label, Single-Arm, Efficacy Study of Tranexamic Acid in Adolescents with Heavy Menstrual Bleeding.
O'Brien SH; Saini S; Ziegler H; Christian-Rancy M; Ahuja S; Hege K; Savelli SL; Vesely SK
J Pediatr Adolesc Gynecol; 2019 Jun; 32(3):305-311. PubMed ID: 30731217
[TBL] [Abstract][Full Text] [Related]
13. Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study.
Archer DF; Stewart EA; Jain RI; Feldman RA; Lukes AS; North JD; Soliman AM; Gao J; Ng JW; Chwalisz K
Fertil Steril; 2017 Jul; 108(1):152-160.e4. PubMed ID: 28579415
[TBL] [Abstract][Full Text] [Related]
14. Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas.
Ip PP; Lam KW; Cheung CL; Yeung MC; Pun TC; Chan QK; Cheung AN
Am J Surg Pathol; 2007 Aug; 31(8):1215-24. PubMed ID: 17667546
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of vilaprisan in women with uterine fibroids: data from the ASTEROID 3 randomized controlled trial.
Al-Hendy A; Zhou YF; Faustmann T; Groettrup-Wolfers E; Laapas K; Parke S; Seitz C
F S Sci; 2023 Nov; 4(4):317-326. PubMed ID: 37437885
[TBL] [Abstract][Full Text] [Related]
16. Estimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleeding.
Lukes AS; Muse K; Richter HE; Moore KA; Patrick DL
Curr Med Res Opin; 2010 Nov; 26(11):2673-8. PubMed ID: 20942615
[TBL] [Abstract][Full Text] [Related]
17. Vilaprisan in women with uterine fibroids: the randomized phase 2b ASTEROID 1 study.
Bradley LD; Singh SS; Simon J; Gemzell-Danielsson K; Petersdorf K; Groettrup-Wolfers E; Ren X; Zvolanek M; Seitz C
Fertil Steril; 2019 Feb; 111(2):240-248. PubMed ID: 30527839
[TBL] [Abstract][Full Text] [Related]
18. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
Barlow DH; Lumsden MA; Fauser BC; Terrill P; Bestel E
Hum Reprod; 2014 Mar; 29(3):480-9. PubMed ID: 24457604
[TBL] [Abstract][Full Text] [Related]
19. LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids.
Al-Hendy A; Venturella R; Arjona Ferreira JC; Li Y; Soulban G; Wagman RB; Lukes AS
Am J Obstet Gynecol; 2023 Dec; 229(6):662.e1-662.e25. PubMed ID: 37666383
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of tranexamic acid in the treatment of idiopathic and non-functional heavy menstrual bleeding: a systematic review.
Naoulou B; Tsai MC
Acta Obstet Gynecol Scand; 2012 May; 91(5):529-37. PubMed ID: 22229782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
